SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017428
Filing Date
2022-08-15
Accepted
2022-08-15 17:33:47
Documents
71
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q icvx-20220630.htm   iXBRL 10-Q 3199795
2 EX-10.1 icvx-ex10_1.htm EX-10.1 183448
3 EX-31.1 icvx-ex31_1.htm EX-31.1 20178
4 EX-31.2 icvx-ex31_2.htm EX-31.2 18754
5 EX-32.1 icvx-ex32_1.htm EX-32.1 10937
6 EX-32.2 icvx-ex32_2.htm EX-32.2 11175
  Complete submission text file 0000950170-22-017428.txt   10520448

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT icvx-20220630_lab.xml EX-101.LAB 512530
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT icvx-20220630.xsd EX-101.SCH 60428
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT icvx-20220630_pre.xml EX-101.PRE 393489
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT icvx-20220630_cal.xml EX-101.CAL 39334
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT icvx-20220630_def.xml EX-101.DEF 254113
65 EXTRACTED XBRL INSTANCE DOCUMENT icvx-20220630_htm.xml XML 1835405
Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Filer) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40655 | Film No.: 221166960
SIC: 2836 Biological Products, (No Diagnostic Substances)